Spinal cord astrocytoma: Response to PCV chemotherapy

Authors:

Abstract
Article abstract Information regarding the value of chemotherapy for spinal cord astrocytomas that progress after irradiation is limited. We describe a patient whose conus medullaris astrocytoma responded to PCV (procarbazine, lomustine, and vincristine) chemotherapy after failing radiation and cisplatin-based chemotherapy. PCV should be considered in patients with progressive spinal cord astrocytomas.

This publication has 9 references indexed in Scilit: